What is fenofibrate used for? Fenofibrate is commonly used to lower bad cholesterol (LDL-C) and increase good cholesterol (HDL-C) in people with high cholesterol or mixed dyslipidemia (elevated ...

Fenofibrate 125–250μM reduced lipopolysaccharide-induced nuclear p65 and p50 subunit activity, “suggesting PPARα treatment directly inhibited NK-κB activation,” she concluded.

Fenofibrate and its active metabolite, fenofibric acid, are primarily excreted by the kidneys. It is nondialysable, and studies in patients with moderate chronic kidney disease (GFR <50 ml/min/1. ...

A new preprint appearing on the bioRxiv* server reports the efficacy of the cholesterol-reducing drug fenofibrate in reducing infection rates of SARS-CoV-2 in cultured cells. The virus must engage ...

Adults taking oral fenofibrate had a 27% reduction in diabetic eye disease progression over 4 years. Fenofibrate is a lipid-lowering drug repurposed for the LENS trial. ORLANDO — The generic ...

Fibrates include gemfibrozil (Lopid), which got the regulatory nod in 1981; fenofibrate (TriCor, Triglide), approved in 2007, and the closely related drug fenofibric acid (TriLipix, Fibricor ...

Use of the cholesterol-lowering drug fenofibrate had a modest but statistically significant association with reduced risk of vision-threatening diabetic retinopathy (VTDR), according to results of ...

(HealthDay)—Fenofibrate therapy may reduce cardiovascular disease (CVD) in statin-treated patients with diabetes and dyslipidemia, according to a study published online Dec. 28 in JAMA Cardiology.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients ...

He is a listed applicant on a patent application in relation to the use of fenofibrate for treatment of diabetic retinopathy. He holds no shares, stocks or options in any pharmaceutical company.